Orchestra BioMed
OBIO
OBIO
23 hedge funds and large institutions have $56.4M invested in Orchestra BioMed in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
91% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 43
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.9M | |
| 2 | +$3.89M | |
| 3 | +$240K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$149K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.1K |
Top Sellers
| 1 | -$9.35M | |
| 2 | -$7.97M | |
| 3 | -$7.34M | |
| 4 |
AC
Amitell Capital
Singapore
|
-$5.98M |
| 5 |
SC
Sculptor Capital
New York
|
-$5.41M |